Rui Liu, Zongwei Li, Rui Chen, Zhihong Fang, Zhiqiang Liu, Huan Liu. "EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction." Nature Communications, 2025. doi:10.1038/s41467-025-56506-5